Back to Search
Start Over
A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients.
- Source :
- Blood, Vol. 92, no. 10, p. 632A-632A (1998)
- Publication Year :
- 1998
Details
- Database :
- OAIster
- Journal :
- Blood, Vol. 92, no. 10, p. 632A-632A (1998)
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1130548492
- Document Type :
- Electronic Resource